logo
Pneumatic tube transportsystem to start at KGMU

Pneumatic tube transportsystem to start at KGMU

Time of India4 days ago

Lucknow: Attendants at KGMU trauma centre will no longer have to run from ward to lab to submit blood samples, as the university is set to introduce a pneumatic tube transport system.
Estimated at around Rs 2 crore, the project was inaugurated by Deputy Chief Minister Brajesh Pathak on Monday. Chief Medical Superintendent of KGMUTC Prof Prem Raj Singh explained that the pneumatic tube transport system is a mechanism for transferring material in bulk. The installation work will commence two months after the tendering process concludes. He further said that the trauma centre includes departments of orthopaedics, general surgery, plastic surgery, neurology, medicine and neurosurgery.
It handles a heavy patient load—around 300 to 400 patients daily—keeping the laboratories occupied round-the-clock. As many patients require multiple tests, attendants are frequently seen moving between different counters.
The new tube system will minimise the need for attendants to move about. Nurses or paramedical staff will place the samples in a designated container with test and patient details. This container will be transported to the lab via a vacuum-based system, saving both time and effort, Prof Singh added. To further cut down queues for diagnostics, KGMU will soon launch a digital payment facility.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Indian pharma market grows 7.2% in May led by chronic therapies
Indian pharma market grows 7.2% in May led by chronic therapies

Business Standard

time43 minutes ago

  • Business Standard

Indian pharma market grows 7.2% in May led by chronic therapies

Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches Sanket Koul New Delhi The Indian Pharma Market (IPM) grew 7.2 per cent in May this year with almost all major therapies showing positive growth, according to market research firm Pharmarack. Data suggest that big chronic therapies such as cardiac and anti-infectives, which account for nearly 25 per cent of the overall domestic market, recorded value growth of 11.7 per cent and 7.6 per cent, respectively. On the other hand, several smaller supergroups such as urology and antineoplastics, which made up 2 per cent each of the IPM's sales value for the month, also recorded double-digit growth in May at 12.3 per cent and 11.7 per cent, said Sheetal Sapale, vice-president, commercial, Pharmarack. Data suggest that the overall value growth for the IPM in May was driven by price growth and new introductions. The IPM also reported a minuscule 0.4 per cent unit growth during the month, with the chronic segments such as antidiabetics (6.1 per cent) and cardiac (4.8 per cent) performing better than the overall market figure. Experts believe that the antidiabetic segment saw a 6.1 per cent rise in volume in May due to a key drug, empagliflozin, going off-patent, as companies launched several plain and combination medications in the segment. Growth in the moving annual turnover (MAT) for the IPM between June 2024 and May 2025 stood at 8.1 per cent, leading to a total turnover of over Rs 2.29 trillion, while volumes in the domestic market grew by 1.1 per cent. The MAT of leading therapy areas such as cardiac, gastrointestinal and anti-infectives, which constitute around 38 per cent of the pharmaceutical market, showed robust volume growth at 10.4 per cent, 9.5 per cent and 6.5 per cent, respectively. While the top 20 brands in the IPM registered modest monthly value growth in the domestic market during the month, Sun Pharma and Dr Reddy's posted significant monthly value growth at 11.2 per cent each. They were followed by Torrent Pharma and Ipca Laboratories at 10.8 per cent, and Alkem Laboratories at 10.3 per cent monthly value growth. According to Pharmarack data, GlaxoSmithKline's (GSK) antibiotic medication Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands at the MAT level, with sales worth Rs 819 crore and Rs 810 crore, respectively.

FDA shuts 3 food businesses at Patradevi, Margao
FDA shuts 3 food businesses at Patradevi, Margao

Time of India

time2 hours ago

  • Time of India

FDA shuts 3 food businesses at Patradevi, Margao

Panaji: The food and drugs administration (FDA) directed two food business operators—a restaurant and a cashew shop—to suspend operations at Patradevi, Pernem, due to unhygienic conditions. The FDA inspected 18 outlets at Patradevi, issued improvement notices, and gave them 14 days to comply. They seized Rs 50,000 worth of food items, including chips, chocolates, and dry fruits with artificial colours. Samples of sweets were also taken for testing. The FDA also directed a restaurant in Margao to shut down for failing to pay a fine and for non-compliance with FDA directions following its inspection on April 28. They found that only 5 of 30 deficiencies were addressed and ordered the food operator to stop all activities and submit a compliance report. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !

Hyderabad-Based Life Circle Wins Prestigious DBS Foundation Impact Beyond Award
Hyderabad-Based Life Circle Wins Prestigious DBS Foundation Impact Beyond Award

News18

time4 hours ago

  • News18

Hyderabad-Based Life Circle Wins Prestigious DBS Foundation Impact Beyond Award

Last Updated: The award includes a grant of SGD 500,000 (approximately Rs 3 crore) to help scale Life Circle's integrated model of home-based eldercare and caregiver training across India Hyderabad-based Life Circle Health Services Pvt. Ltd., a pioneering Indian eldercare company, has been named one of the four global winners of the DBS Foundation Impact Beyond Award 2025. The award includes a grant of SGD 500,000 (approximately Rs 3 crore) to help scale Life Circle's integrated model of home-based eldercare and caregiver training across India. This recognition from DBS Foundation, the philanthropic arm of DBS Bank, underscores Life Circle's mission to address India's growing need for quality senior care by building a sustainable caregiving workforce and delivering compassionate home-based services. Life Circle joins three other winners from Singapore, Hong Kong, and China. All winners were honoured at the Impact Beyond Dialogue; a flagship DBS Foundation event held at Marina Bay Financial Centre in Singapore.'We are honoured to receive the DBS Foundation Impact Beyond Award. This validates our belief that India's eldercare transformation must begin with professionalising caregivers," said Anant Kumar, CEO & Founder of Life Circle. LIFE CIRCLE Life Circle claims to be India's leading eldercare platform, delivering quality home-based care while creating dignified livelihoods for caregivers. With its tech-enabled services, certified caregiver training, and growing nationwide presence, Life Circle is building the foundation for India's ageing population to thrive at home. Founded by healthcare and social impact professionals, Life Circle is India's only full-stack eldercare company combining, Training & certification via Care Skills Academy, Digital skilling through Care Tube app, Technology-enabled home care matching seniors with certified caregivers, Job creation with a focus on women and underserved youth Life Circle's caregivers conduct over 100,000 home visits annually and have achieved a 96% client satisfaction rate. Over 5,000 caregivers have been placed to date—76% of them rural women. Life Circle is also incubated by T-Hub (India's premier innovation hub) and the Asia Pacific Care Accelerator, supported by UN Women and the Indian Government. THE DEMOGRAPHIC India will soon be home to over 150 million seniors, yet 97% of caregivers remain informal and untrained. Many women drop out of the workforce to care for ageing parents and relatives. Constant increase in life expectancy due to improvement in the health care facilities over the years is one of the main reasons for rapid increase in proportion of population of senior citizens. As per Census 2011, the total population of Senior Citizens (people aged 60 years and above) is 10.38 crore, of which population of males and females are 5.11 crore and 5.27 crore, respectively. Expectation of life at birth for males/female has shown a steady rise. Govt of India and many non-government organisations are working tirelessly to deliver home based care to the elderly. They are getting tremendous support from the government and private sector as well. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! First Published: June 06, 2025, 17:16 IST

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store